-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311.O1.6 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Mechanisms and Treatment of ITP

Symposia: Disorders of Platelet Number or Function: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, autoimmune disorders, Biological therapies, Antibody Therapy, bleeding disorders, adult, Translational Research, Non-Biological therapies, assays, epidemiology, Clinical Research, platelet disorders, Diseases, thrombocytopenias, Immune Disorders, immune mechanism, Therapies, thrombotic disorders, immunology, real-world evidence, Biological Processes, Technology and Procedures, profiling, Study Population, Human
Monday, December 12, 2022: 4:30 PM-6:00 PM
220-222 (Ernest N. Morial Convention Center)
Moderators:
Taylor Olmsted Kim, MD, Texas Children’s Cancer and Hematology Centers and Ana G Antun, MD, Emory University
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Nina Shaver1*, Oluwamayokun Oshinowo, BS1, Meredith E. Fay, BS1*, David R. Myers, PhD1 and Wilbur A Lam, MD, PhD1,2,3

1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
2Children’s Healthcare of Atlanta, Atlanta, GA
3Parker H. Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA

4:45 PM

Feng-Qi Liu1,2,3,4*, Qingyuan Qu5,6,7,8*, Qi Chen9,10,11,12*, Hai-xia Fu1,2,3,13*, Kaiyan Liu, MD, PhD9,10,12,14 and Xiao-hui Zhang1,2,3,13*

1Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China
2National Clinical Research Center for Hematologic Disease, Beijing, China
3Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
4Collaborative Innovation Centre of Hematology, Peking University, Beijing, China
5Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, beijing, China
6Peking University People’s Hospital, Peking University Institute of Hematology, beijing, China
7National Clinical Research Center for Hematologic Disease, beijing, China
8Collaborative Innovation Centre of Hematology, beijing, China
9National Clinical Research Center for Haematologic Disease, Beijing, China
10Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China
11Peking University People’s Hospital, Peking University Institute of Haematology, Beijing, China
12Collaborative Innovation Centre of Haematology, Peking University, Beijing, China
13Collaborative Innovation Center of Hematology, Peking University, Beijing, China
14Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China., Beijing, China

5:00 PM

Amna Malik, PhD1*, Michelle MH Tan, MSc1*, Anwar A Sayed, PhD, MBBS, MSc1,2, Panpan Han3,4*, Eleanor Watt5*, Adela Constantinescu-Bercu1*, Ahmad Khoder, MD, PhD, MRCP, ASCP1*, Alexander TH Cocker6,7*, Emma Thorley, MB BChir, BA8*, Ariam Teklemichael, BSc8*, Yunchuan Ding, PhD1*, Rocel C. Saputil, MSc1*, Alice C J Hart, MBBS, BSc, MRCP, FRCPath1,9*, Haiyu Zhang4*, Wayne A. Mitchell, PhD10*, Nesrina Imami, PhD7*, James TB Crawley, PhD1*, Isabelle Salles-Crawley1*, James B. Bussel, MD11, James L Zehnder, MD12, Stuart Adams, PhD5*, Bing Melody Zhang4* and Nichola Cooper, MD1

1Centre For Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
2Department of Medical Microbiology and Immunology, Taibah University, Medina, Saudi Arabia
3Department of Hematology, Qilu Hospital, Shandong University, Jinan, Shandong, China
4Department of Pathology, Stanford University School of Medicine, Stanford
5SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
6Department of Structural Biology, Stanford University School of Medicine, Stanford
7Centre For Immunology and Vaccinology, Imperial College London, London, United Kingdom
8Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom
9Imperial College Healthcare NHS Trust, Hammermsith Hospital, London, United Kingdom
10Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
11Department of Pediatrics, Weill Cornell Medicine, New York, NY
12Department of Pathology, Stanford University School of Medicine, Stanford, CA

5:15 PM

Hui Yuan Li*, Xueqing Dou*, Yunfei Chen, MD*, Renchi Yang, MD and Lei Zhang, MD*

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

5:30 PM

Khanittha Siritham, MD*, Piangrawee Niprapan, MNS*, Nonthakorn Hantrakun*, Teerachat Punnachet, MD*, Thanawat Rattanathammethee, MD*, Sasinee Hantrakool, MD*, Chatree Chai-Adisaksopha, MD, PhD, Ekarat Rattarittamrong, MD*, Adisak Tantiworawit, MD, Lalita Norasetthada, MD and Pokpong Piriyakhuntorn, MD*

Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

5:45 PM

Xiyan Wang, PHD1*, Xiaofan Liu, MD2*, Yueshen Ma3*, Jiao Wang4*, Rongfeng Fu, MD5*, Yunfei Chen, MD5*, Wei Liu5*, Ting Sun, MD5*, Mankai Ju5*, Hui Yuan Li6*, Feng Xue, MD7*, Changping Li4*, Zhen Song1*, Lei Zhang, MD5* and Renchi Yang, MD5

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, China, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, CHN, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
4Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, China, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, CHN, China, Tianjin, China
7State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, AL, China

*signifies non-member of ASH